trans-o-flex: Covid-19 vaccines can be safely transported at 2 to 8 degrees Celsius

.

  • The logistics service provider specialising in the transport of pharmaceuticals attributes demands for worldwide storage and transport temperatures of minus 80 degrees to a lack of expert knowledge
  • trans-o-flex’s ThermoMed special network is available for the local distribution of vaccines in Germany and Austria
  • Active temperature control at 2 to 8 degrees, i.e. monitoring, control and documentation of compliance with the temperature range, is suitable for ruling out a possible reduction in the efficacy of Covid-19 vaccines during transport

trans-o-flex, the pharmaceutical logistics company specialising in the transport of pharmaceuticals, rejects reports according to which logistics companies would have to set up networks worldwide for the transport of Covid-19 vaccines in which the products can be stored and transported at minus 80 degrees Celsius. "Anyone who knows just a little bit about the pharmaceutical industry understands that the hastily communicated temperatures of between minus 20 and minus 80 degrees Celsius are precautions that companies must take until they have valid data on the storage life of their products also at higher temperatures," said trans-o-flex CEO Wolfgang P. Albeck. "In fact, several companies have now confirmed that Covid-19 vaccine candidates retain their efficacy even if they are treated like normal cold chain products, i.e. stored and transported at 2 to 8 degrees Celsius". Albeck cited the companies Biontech and Curevac as examples. Mainz-based Biontech, which is developing a Covid-19 vaccine together with the pharmaceutical company Pfizer, announced at a press conference that its vaccine could be stored at 2 to 8 degrees for five days. And, according to Albeck, the company intends to announce further assured results shortly. It can be assumed that the company will certify that its product has a significantly longer stability at refrigerator temperature. The Tübingen-based company Curevac, which is researching another vaccine candidate against Covid-19, has even confirmed that its vaccine against Covid-19 exhibits "stability over several months" at two to eight degrees Celsius.

From all this, trans-o-flex concludes that Covid-19 vaccines are also most likely to be classified as cold chain products that can be safely transported at so-called refrigerator temperature. "Thanks to our actively temperature-controlled networks, we are therefore optimally prepared for a nationwide distribution of Covid-19 vaccines," says Wolfgang P. Albeck. "The subsidiary trans-o-flex ThermoMed, which specialises in distribution in the temperature range between 2 and 8 degrees Celsius, can deliver Covid-19 vaccines, just like the influenza vaccines of recent years, to all doctors, pharmacies, hospitals and pharmaceutical wholesalers in Germany and Austria in a safe and transparently documented manner.

Über trans-o-flex Express GmbH & Co. KGaA

trans-o-flex core areas of expertise are logistics solutions for the pharmaceutical, cosmetics and consumer electronics industries and for other high-end, sensitive goods. The company has built up transport networks that convey goods at 15 to 25 degrees Celsius or at 2 to 8 degrees Celsius actively temperature-controlled and documented in accordance with EU regulations for the transport of pharmaceuticals. These EU-GDPs require the highest standards for safety and security, cleanliness, reliability and transparency, from which all trans-o-flex customers benefit. trans-o-flex operates internationally via the networks EUROTEMP (temperature-controlled logistics) and EURODIS (in 36 European countries). In contrast to conventional parcel services or forwarding agencies, trans-o-flex delivers goods in parcels as well as on pallets. trans-o-flex Express also offers numerous express and time-slot deliveries, special services such as dangerous goods transportation (without minimum quantity regulation), consignment consolidation or direct deliveries. The express shipments are complemented by warehousing, order picking and individual value-added services such as serialisation of pharmaceuticals. This means that the company covers the entire logistics chain from procurement through to fulfilment. The annual business volume of the trans-o-flex companies, which employ a total of around 2,200 people, amounted to around 495 million euros in 2019. More information is available at www.trans-o-flex.com.

Firmenkontakt und Herausgeber der Meldung:

trans-o-flex Express GmbH & Co. KGaA
Hertzstraße 10
69469 Weinheim
Telefon: +49 (6201) 988-0
Telefax: +49 (6201) 988-980
http://www.trans-o-flex.com

Ansprechpartner:
Sabine Kolaric
Leiterin Unternehmenskommunikation
Telefon: +49 (6201) 988-134
Fax: +49 (6201) 988-343
E-Mail: pr@tof.de
Für die oben stehende Pressemitteilung ist allein der jeweils angegebene Herausgeber (siehe Firmenkontakt oben) verantwortlich. Dieser ist in der Regel auch Urheber des Pressetextes, sowie der angehängten Bild-, Ton-, Video-, Medien- und Informationsmaterialien. Die United News Network GmbH übernimmt keine Haftung für die Korrektheit oder Vollständigkeit der dargestellten Meldung. Auch bei Übertragungsfehlern oder anderen Störungen haftet sie nur im Fall von Vorsatz oder grober Fahrlässigkeit. Die Nutzung von hier archivierten Informationen zur Eigeninformation und redaktionellen Weiterverarbeitung ist in der Regel kostenfrei. Bitte klären Sie vor einer Weiterverwendung urheberrechtliche Fragen mit dem angegebenen Herausgeber. Eine systematische Speicherung dieser Daten sowie die Verwendung auch von Teilen dieses Datenbankwerks sind nur mit schriftlicher Genehmigung durch die United News Network GmbH gestattet.

counterpixel